Download Cancer Activity Level Reporting (ALR) / Ontario Cancer Registry

CCO DataBook 2008-2009
Cancer Activity Level Reporting (ALR) /
Ontario Cancer Registry (OCR)
Published for Cancer Care Ontario’s Partner Organizations
THIS DOCUMENT CONTAINS PROPRIETARY INFORMATION
Do not disclose without the prior approval of Cancer Care Ontario
i
Table of Contents
Table of Contents
Cancer Activity Level Reporting (ALR) / Ontario Cancer Registry (OCR).................. 1
Defining the Activity for Inclusion ..................................................................... 1
ALR > Patient ................................................................................................ 2
ALR > Disease ............................................................................................... 5
ALR > Healthcare Professional ........................................................................15
ALR > Clinic Visit ..........................................................................................17
ALR > Radiation Planning / Treatment Activity ..................................................21
ALR > Systemic Drug Delivery Event ...............................................................26
ALR > Procedure...........................................................................................32
ALR > NDFP Enrollment .................................................................................35
ii
Introduction
I. Cancer Activity Level Reporting (ALR) / Ontario Cancer Registry (OCR)
Activity Level Reporting (ALR) data represents the basic set of data elements required to produce the quality, cost and
performance indicators for the cancer system. The data elements constitute patient level activity within the cancer system
focused on radiation and systemic therapy services and outpatient oncology clinic visits. This data is also a key component of
the Ontario Cancer Registry (OCR), which registers every malignant neoplasm diagnosed in Ontario.
Note: 0809 Changes highlighted in blue
Defining the Activity for Inclusion
An Integrated Cancer Program encompasses the delivery of all cancer services regardless of where that service is delivered in
your facility. We realize that this may present challenges from a data perspective, since some oncology clinical processes may
not be integrated as yet.
CCO requires all activity from the cancer centre and its related outreach clinics, if any. In addition, please include all outpatient
chemotherapy treatment visits that occur in the host hospitals (MIS functional centre 7134066). No other reporting from the
host hospitals will be required for this year (such as oncology clinics).
It is not CCO's intent to duplicate the existing inpatient Discharge Abstract Data to CIHI. Therefore, we do not want data from
your inpatient nursing units, nor from your day surgery areas. We do however want to know if oncology inpatients physically
attend outpatient clinics or treatment areas in the cancer centre. Those occurrences should already be captured in your
existing cancer centre systems.
CCO DataBook 2008-2009
1
Patient
ALR > Patient
Entity
Data Element
Definition
Patient
Patient Chart
Number
Patient identifier
CHAR 10
Consistent with CIHI
code that is unique Alpha-numeric NACRS and DAD
within the
definition and format.
healthcare facility.
Patient
Submitting
MOHLTC facility
CHAR 4
Hospital Number number of the
Numeric
healthcare facility
where this patient is
registered.
Patient
Patient Surname Patient surname.
CHAR 50
Patient
Patient Maiden
Name
Patient maiden
name.
CHAR 50
Patient
Patient First
Name
Patient first given
name.
CHAR 40
CCO DataBook 2008-2009
Format
Valid Values
Purpose and Use
Applies To:
2008/2009 Changes
Uniquely identifies a All
patient within an
ICP. Necessary to
determine a case.
Foundational to
most measures and
indicators.
Valid MOHLTC facility Uniquely identifies All
numbers only. Same the hospital
3-digit number that is organization
used for MIS
reporting this
submissions. An
patient.
additional leading zero
is acceptable.
For current valid
MOHLTC facility
numbers, see Appendix
A.
Truncate if name
Required for the
All
longer than 50
Ontario Cancer
characters.
Registry to allow
linking with other
datasets (e.g. death
registrations).
Truncate if name
Used by the Ontario Optional
longer than 50
Cancer Registry to
characters.
allow linking with
other datasets (e.g.
death registrations).
All
Truncate if name
Required for the
longer than 40
Ontario Cancer
characters.
Registry to allow
linking with other
datasets (e.g. death
registrations).
2
Patient
Entity
Data Element
Definition
Patient
Patient Middle
Name
Patient second given CHAR 40
name.
Patient
Patient Gender
Patient gender.
CHAR 1
Patient
Patient Birth
Date
Patient birth date.
YYYYMMDD
Patient
Patient Death
Date
The date the patient YYYYMMDD
died. (if known)
CCO DataBook 2008-2009
Format
Valid Values
Purpose and Use
Applies To:
2008/2009 Changes
Truncate if name
longer than 40
characters.
Used by the Ontario Optional
Cancer Registry to
allow linking with
other datasets (e.g.
death registrations).
M = Male, F = Female, Required for the
All
O = Other
Ontario Cancer
(transsexual,
Registry to allow
hermaphrodite).
linking with other
As per CIHI NACRS
datasets (e.g. death
definition.
registrations).
Allows sex-adjusted
incidence to be
calculated.
Ontario Cancer
Registry
Valid dates only.
For analyses
All
involving patient
age and registry
linking.
Planning, Ontario
Cancer Registry,
MIS, NACRS, and
funding.
Valid dates or NULL.
For record linkage Optional
purposes.
Ontario Cancer
Registry.
3
Patient
Entity
Data Element
Definition
Patient
Health Card
Number
Patient’s most
recent health
insurance number
assigned by their
provincial
government of
residence.
Patient
Patient
Patient
Patient
Format
Valid Values
Purpose and Use
CHAR 12
The following Values
To identify OHIP vs.
Alpha-numeric are only to be used
non-OHIP patients.
when unable to provide Also used for
a Health Care
registry linking.
Number.
Planning, Ontario
0 = insured resident of Cancer Registry,
reporting province, but MIS, NACRS.
HCN not available
1= not applicable,
includes: Out of
province resident with
unavailable HCN, Out
of Country, no health
insurance coverage
from province of
residence
Health Card
Version number of CHAR 2
As per MOHLTC OHIP Used for registry
Version
the patient’s most
rules. Leave blank for linking.
recent provincial
non-OHIP patients.
Ontario Cancer
health card.
Registry.
Province Issuing Province that issued CHAR 2
Use official 2-letter
Identifies OHIP
Health Card
this health card
abbreviation as per
versus non-OHIP
number.
CIHI. See Appendix 7 patients. Used for
registry linking.
Planning, Ontario
Cancer Registry,
NACRS
Responsibility
Pyment code that
CHAR 2
See Appendix D for
Used for NACRS
for Payment
identifies the
possible values.
only.
primary group
responsible for
payment of
service(s) rendered.
Host Hospital
Patient identifier
CHAR 10
Alpha-numeric.
Used for NACRS
Patient Chart
code used by the
Consistent with CIHI
only.
Number
host hospital for
NACRS and DAD
reporting to CIHI.
definition and format.
If alpha, must be upper
case.
CCO DataBook 2008-2009
Applies To:
2008/2009 Changes
All
Revised
All
All
OPIS only
OPIS only,
optional
4
Disease
ALR > Disease
Entity
Data Element
Disease
Patient Chart Number Patient identifier code CHAR 10
Consistent with CIHI
that is unique within
Alpha-numeric. NACRS and DAD
the healthcare facility.
definition and format.
Disease
Submitting Hospital
Number
CCO DataBook 2008-2009
Definition
Format
MOHLTC facility
CHAR 4
number of the
Numeric
healthcare facility
reporting this disease.
d Values
Purpose and Use
Applies To
2008/2009 Changes
Uniquely identifies a
All
patient within an ICP.
Necessary to
determine a case.
Foundational
to most measures and
indicators.
Uniquely identifies the All
Valid MOHLTC facility
numbers only. Same 3- hospital organization
that is reporting this
digit number that is
disease.
used for MIS
submissions. An
additional leading zero is
acceptable.
For current valid
MOHLTC facility
numbers, see Appendix
A.
5
Disease
Entity
Data Element
Disease
Diagnosis Code
Disease
Definition
Format
CHAR 7
The primary disease
site, or whatever other
condition caused this
patient to be
registered at the ICP.
Note that this is NOT
the same as the
Primary Problem field
in NACRS.
All newly diagnosed
patients must have an
ICD-10-CA code. For
patients diagnosed in
prior years, submit this
code using the ICD
version in effect at
that time.
Note: This should not
be used to report
Cancer Diagnosis.
Topography and
Morphology must be
used
Diagnosis Code VersionICD version of the
CHAR 3
diagnosis code.
CCO DataBook 2008-2009
d Values
Purpose and Use
Applies To
Only valid ICD-8, -9, - Used to report activity All
by disease site group.
9CM, or -10 codes
accepted. See Appendix Used to report
incidence and mortality
I for detailed list and
descriptions of ICD-10- rates by cancer type,
CA.
ALR, Wait Times, and
For patients diagnosed funding.
in prior years, use the
ICD version in effect at
that time and submit the
appropriate Diagnosis
Code Version. Effective
April 1, 2008 for new
cases use the ICD10CA
8 = ICD-8
9 = ICD-9
9CM = ICD-9-CM
10 = ICD-10-CA
2008/2009 Changes
Revised
Used for patients
All
registered in prior
years. Allows the
original diagnosis to be
used in historical
analyses if necessary.
6
Disease
Entity
Data Element
Definition
Format
d Values
Purpose and Use
Applies To
CHAR 4
Please refer to Appendix To facilitate T, N, M
The primary cancer
alphanumeric 2
validation and
disease site that
derivation of best
caused this patient to
stage.
be registered at the
ICP.
All newly diagnosed
patients must have an
ICD-0-3 Topography
code. For patients
diagnosed in prior
years, submit this code
using the ICD version
in effect at that
time.Topography code
describing the site of
the neoplasm at time
of diagnosis*1
*1 International Classification of Diseases for Oncology, 3rd Edition (ICD-O-3). Retrieved on Nov 28, 2006 from
http://www.who.int/classifications/icd/adaptations/oncology/en/
All
New diagnoses should use Used for calculating
incidence rates.
the morphology codes
Ontario Cancer
from ICD-O-3.
Registry
Recurrences of cancers
diagnosed in prior years
can be reported using
whatever version of ICD-O
was originally used.
Note: Version 3 to be
used for NEW registrations
effective April 1, 2008
Exclude non-numeric
symbols, such as slashes
(/).
All
Disease
Topography Code
Disease
Morphology Code
CCO DataBook 2008-2009
Morphology code
describing the
microscopic anatomy
of the neoplasm at
time of diagnosis.
CHAR 5
2008/2009 Changes
Revised
7
Disease
Entity
Data Element
Disease
Topography/Morpholo Version of ICD-O that CHAR 2
gy Code Version
was used for the
Topography/Morpholog
y Code.
Disease
Basis of Diagnosis
Code describing the
CHAR 1
method of original
diagnosis, i.e. how the
diagnosis was
confirmed.
Disease
Date of Initial
Diagnosis
Date of initial diagnosis YYYYMMDD
by a physician for this
disease. May be
clinical or pathological,
but should be chosen
with the following
priority listing:
1) Date of first
histology or cytology
confirmation of
malignancy (date
specimen taken); 2)
Date of admission to
hospital, or date of
first outpatient
consultation.
CCO DataBook 2008-2009
Definition
Format
d Values
Purpose and Use
Applies To
2008/2009 Changes
M – MOTNAC
All
Used for calculating
1 – ICD-O-1
incidence rates.
FT – ICD-O Field Trial
Ontario Cancer
(1988-92)
Registry
2 – ICD-O-2
3– ICD-O-3
Note: Version 3 to be
used for NEW registrations
effective April 1, 2008
See Appendix M for
Analysis of incidence All
possible values.
and survival may be
confined to microconfirmed cases only.
Ontario Cancer
Registry.
Valid dates only.
Used for incidence rate All
If diagnosis is made at
calculations.
another facility and is not Ontario Cancer
known, use an
Registry.
approximation.
Revised
8
Disease
Entity
Data Element
Definition
Format
Disease
Diagnosis Hospital
Number
If the diagnosis was
not made in this ICP,
indicate the hospital
where the diagnosis
was made.
CHAR 4
Disease
Diagnosis Hospital
Chart Number
A patient identifier
CHAR 10
which is unique to the AlphaDiagnosing Hospital.
numeric.
Disease
Patient Postal Code at Patient’s postal code of CHAR 10
Diagnosis
their home address on
the date of diagnosis.
Disease
Patient MOHLTC
Residence Code at
Diagnosis
Patient’s residence
CHAR 4
code of their home
address on the date of
diagnosis.
Disease
Registration Date
Date this patient was YYYYMMDD
first registered at this
ICP for this disease, or
the date of the
patient’s first visit at
this ICP for this
disease.
CCO DataBook 2008-2009
d Values
Numeric, valid MOHLTC
master numbers or NULL
only. Same as CIHI’s
Institution Number for
NACRS submissions, but
does not include CIHI’s
provincial identifier digit.
If diagnosis is made in the
submitting ICP, then leave
this field blank.
For current valid MOHLTC
master numbers, see
Appendix A.
Consistent with CIHI
NACRS and DAD definition
and format.
Purpose and Use
Applies To
2008/2009 Changes
Used for linking
All
patient records in the
Ontario Cancer
Registry.
Used for linking
All
patient records in the
Ontario Cancer
Registry.
All
Canadian postal codes
Used for generating
must be in the format
incidence rates by
geographic region, and
ANANAN (no space),
where A is a letter and N isfor registry linking.
Planning, Ontario
a number. For US zip
codes, use either NNNNN Cancer Registry
or NNNNN-NNNN. CIHI’s
two-letter province/state
codes are also acceptable
if full code not known or
for non-Canadian
residence. See Appendix
9.
Numeric only. Must be a Used for calculating
OPIS only,
valid MOHLTC residence
incidence rates by
optional
code. See Appendix B.
MOHLTC region.
Ontario Cancer
Registry
Valid dates only.
Used as a proxy for
All
Date must be equal to or Referral Date if
before patient’s first visit missing for wait times.
at this centre for this
Used to derive Disease
disease.
Number for non-OPIS
ICPs.
Revised
Revised
9
Disease
Entity
Data Element
Definition
Disease
Disease Sequence
Number
Numeric sequence of INTEGER
this primary cancer for
this patient in this ICP.
Captured in OPIS, but
derived from Disease
Registration Date for
non-OPIS ICPs.
Disease
Format
d Values
Purpose and Use
Applies To
2008/2009 Changes
1 through 99.
When combined with a OPIS only
patient identifier,
disease sequence
number uniquely
defines a cancer case.
Used in ALR, Ontario
Cancer Registry, Wait
Times, Planning, and
funding.
Yes – patient receives
To be used to identify All
surgical treatment or
cancer cases where
biopsy as defined in the
only surgery (resection
list of qualifying ICD-10
or biopsy) is
and CCI codes (see
performed for the
Appendix CC) without a
purposes of expansion
referral to the ICP cancer of stage data capture.
centre.
No or Null – patient did
not receive surgical
treatment or biopsy as
defined in the list of
qualifying ICD-10 and CCI
codes or patient had a
referral to the ICP cancer
centre.
First Definitive Cancer Patient receives
CHAR 1
Revised
Surgery Treatment or cancer surgical
Biopsy Flag
treatment or biopsy at
the ICP host hospital
without a referral to
the ICP cancer centre
*2
Flag should be
indicated for newly
diagnosed cancer
patient receiving
definitive surgery for
first course of cancer
treatment or a biopsy
only if no additional
surgery is done.
For example, if a
patient has a
hemicolectomy at the
host hospital a flag of
‘Yes’ should be
assigned.
* 2 This applies to cases with most responsible diagnoses included in the list of qualifying cancer ICD-10 codes provided (attached) and surgical procedures
listed in the CCI codes provided (see Appendix CC). When multiple surgeries are performed on the patient, the stage should be assigned based on the
information associated with the most definitive surgery (in which the greatest amount of disease or potential disease was removed). If only a biopsy is done
on the case with no resections, then the stage should be assigned based on the information from the biopsy. Note that surgeries or biopsies performed on in
situ cases within stageable diseases are considered stageable and should be included.
CCO DataBook 2008-2009
10
Disease
Entity
Data Element
Disease
First Definitive Surgical The date that the
YYYMMDD
Treatment or Biopsy definitive cancerDate
related surgery was
performed.
Alternatively, if only a
biopsy is performed
(and no other surgery)
the date of the
biopsy. This date
corresponds with the
First Definitive Cancer
Surgery Treatment or
Biopsy Flag and should
be indicated for newly
diagnosed cancer
patient receiving
definitive surgery for
first course of cancer
treatment (or a biopsy
in the absence of
definitive surgery).
Valid Dates Only.
Required Only If
Cancer Surgical
Treatment Flag Is
Value Of “Y”.
To identify the date All
for which the 6 month
stage at diagnosis
rule will be applied.
Disease
Clinical Stage at
Diagnosis
CHAR 10
See Appendix C for
CCO Cancer Staging
Policy and AJCC
website.
e.g. 2A or 2
Disease
Clinical Stage, T
Clinical T Category
Category at Diagnosis (tumour) for TNM
stage at date of
diagnosis.
CHAR 10
See Appendix C for
CCO Cancer Staging
Policy and AJCC
website.
e.g. TX, T1, T1a, etc
Used to comply with
CCO staging policy.
Concordance with
evidence-based
practice guidelines.
Disease staging
report. Ontario
Cancer Registry.
Used to comply with
CCO staging policy.
Concordance with
evidence-based
practice guidelines.
Disease staging
report. Ontario
Cancer Registry.
CCO DataBook 2008-2009
Definition
Clinical TNM stage
group at the date of
diagnosis.
Format
d Values
Purpose and Use
Applies To
2008/2009 Changes
Revised
All
All
11
Disease
Entity
Data Element
Disease
Clinical Stage, N
Clinical N Category
CHAR 10
Category at Diagnosis (nodes) for TNM stage
at date of diagnosis.
Disease
Clinical Stage, M
Clinical M Category
Category at Diagnosis (metastasis) for TNM
stage at date of
diagnosis.
Disease
Pathological Stage at
Diagnosis
Disease
Pathological Stage, T Pathological T
CHAR 10
Category at Diagnosis Category (tumour) for
TNM stage at date of
diagnosis.
Disease
Pathological Stage, N Pathological N
Category at Diagnosis Category (nodes) for
TNM stage at date of
diagnosis.
CCO DataBook 2008-2009
Definition
Format
CHAR 10
Pathological TNM stage CHAR 10
group at date of
diagnosis.
CHAR 10
d Values
See Appendix C for
CCO Cancer Staging
Policy and AJCC
website.
e.g. NX, N0, N1, N1a
Purpose and Use
Used to comply with
CCO staging policy.
Concordance with
evidence-based
practice guidelines.
Disease staging
report. Ontario
Cancer Registry.
See Appendix C for
Used to comply with
CCO Cancer Staging
CCO staging policy.
Policy and AJCC
Concordance with
website.
evidence-based
e.g. MX, M0, M1, M1a practice guidelines.
Disease staging
report. Ontario
Cancer Registry.
See Appendix C for
Used to comply with
CCO Cancer Staging
CCO staging policy.
Policy and AJCC
Concordance with
website.
evidence-based
e.g. 2A, 2
practice guidelines.
Disease staging
report. Ontario
Cancer Registry.
See Appendix C for
Used to comply with
CCO Cancer Staging
CCO staging policy.
Policy and AJCC
Concordance with
website.
evidence-based
e.g. T1, T1a
practice guidelines.
Disease staging
report. Ontario
Cancer Registry.
See Appendix C for
Used to comply with
CCO Cancer Staging
CCO staging policy.
Policy and AJCC
Concordance with
website.
evidence-based
e.g. N1, N1a
practice guidelines.
Disease staging
report. Ontario
Cancer Registry.
Applies To
2008/2009 Changes
All
All
All
All
All
12
Disease
Entity
Data Element
Disease
Pathological Stage, M Pathological M
CHAR 10
Category at Diagnosis Category (metastasis)
for TNM stage at date
of diagnosis.
Disease
Staging Version
CHAR 2
Version of the AJCC
TNM staging manual
used for staging this
disease.
All new diseases
should be staged using
the 6th edition.
FIGO version (per
AJCC 6th)
Disease
Analytic Flag
To facilitate valid stage CHAR 1
reporting and use.
This field will help to
identify analytic cases
for purposes of staging
Disease
Date of Referral to a
Medical Oncologist
Disease
Date of Referral to a
Radiation Oncologist
Disease
Date of Referral to a
Surgical Oncologist
Date of first referral to YYYYMMDD
a Medical Oncologist,
based on the date the
referral is received.
Date of first referral to YYYYMMDD
a Radiation Oncologist,
based on the date the
referral is received.
Date of first referral to YYYYMMDD
a Surgical Oncologist,
based on the date the
referral is received.
CCO DataBook 2008-2009
Definition
Format
d Values
Purpose and Use
Applies To
Used to comply with All
CCO staging policy.
Concordance with
evidence-based
practice guidelines.
Disease staging
report. Ontario
Cancer Registry.
06 – AJCC 6th Edition Identifies the staging All
version that was used
FF – FIGO (per AJCC for this patient.
Current cases should
6th)
be staged using
version 06, but those
staged in prior years
may have used an
earlier version. FIGO
code added to identify
Gynecology related
Stage capture
0 = Class of case
To identify the reason All
Unknown/Reason for the case was referred
referral
to the ICP
1 = Analytic Case
2 = Non Analytic Case
See APPENDIX G
2008/2009 Changes
See Appendix C for
CCO Cancer Staging
Policy and AJCC
website.
e.g. MX, M0, M1, M1a
Valid dates only.
Calculation of wait
times by program.
Wait Times reports
All
Valid dates only.
Calculation of wait
times by program.
Wait Times reports
All
Valid dates only.
Calculation of wait
times by program.
Wait Times reports
All
Revised
New
13
Disease
Entity
Data Element
Definition
Disease
Laterality
Identifies the side of a CHAR 1
paired organ or the
side of the body on
which the reportable
tumour originated.
This applies to the
primary site only.
See FORDS manual,
page 92 at
http://www.facs.org/c
ancer/coc/fords/fordsh
ighlighted0605.pdf
CCO DataBook 2008-2009
Format
d Values
Purpose and Use
0 Organ is not
To capture laterality
considered to be a
where ICD-03
paired side.
Topography codes.
1 Origin of primary is currently do not.
right.
Appendix 6 for
2 Origin of primary is laterality with
left.
Topography codes
3 Only one side
involved, right or left
origin not specified.
4 Bilateral
involvement, side of
origin unknown, stated
to be a single primary.
9 Paired site, but
lateral origin unknown;
midline tumour.
Applies To
All
2008/2009 Changes
Revised
14
Healthcare Professional
ALR > Healthcare Professional
Entity
Data Element
Healthcare
Professional
Submitting
MOHLTC facility number
Hospital Number of the healthcare facility
where this healthcare
professional provides
services to patients.
Healthcare
Professional
HCP Number
Healthcare
Professional
HCP Specialty
Code
Healthcare
Professional
CCO Program
Code
CCO DataBook 2008-2009
Definition
Format
Valid Values
CHAR 4
Numeric
Uniquely identifies the
All
Valid MOHLTC facility
numbers only. Same 3- hospital organization of this
digit number that is used healthcare professional.
for MIS submissions. An
additional leading zero is
acceptable.
For current valid MOHLTC
facility numbers, see
Appendix A.
Numeric only as per CIHI Uniquely identifies a
All
NACRS format.
healthcare professional so
patient activity can be linked
to a program.
A healthcare professional CHAR 15
identifier code unique to
the submitting healthcare
facility. These codes can
be assigned to any type
of healthcare
professional, not just
physicians.
This has historically been
the physician’s OHIP
billing number.
Credentialed specialty of CHAR 5
the healthcare
professional according to
CIHI service provider
code.
Primary cancer program CHAR 3
affiliation of this
physician. Not applicable
to other types of
healthcare professionals.
For healthcare
professionals who have
multiple specialties, use
their primary specialty.
See CIHI list in Appendix
H.
Must be one of Radiation
(RAD), Systemic (SYS),
Surgical (SUR),
Supportive Care (SC),
Research (RE), Palliative
(PA), or Preventive
oncology (PO).
Purpose and Use
Applies
To:
2008/09 Changes
Used to identify the type of All
healthcare professional for
planning purposes.
Allows activity to be
reported by program.
All
15
Healthcare Professional
Entity
Data Element
Definition
Healthcare
Professional
HCP Surname
Healthcare professional’s CHAR 20
surname.
Truncate if name greater Used to identify healthcare
than 20 characters.
professionals who work in
multiple ICPs.
Healthcare
Professional
HCP First Name
Healthcare professional’s CHAR 15
first name or initials.
Healthcare
Professional
HCP Status
Truncate if name greater Used to identify healthcare All
than 15 characters.
professionals who work in
multiple ICPs.
A = Active or I =
Used to identify active
All
Inactive.
healthcare professionals for
planning purposes.
Healthcare
Professional
Format
Defines whether the
CHAR 1
healthcare professional is
in active practice at this
ICP.
Host Hospital HCP Healthcare professional CHAR 15
Number
identifier used by the
host hospital for reporting
to CIHI.
CCO DataBook 2008-2009
Valid Values
Purpose and Use
Numeric only as per CIHI Used for NACRS reporting
NACRS format.
only.
Applies
To:
2008/09 Changes
All
OPIS only,
optional
16
Clinic Visit
ALR > Clinic Visit
Entity
Data Element
Definition
Clinic Visit
Patient Chart
Number
Patient identifier code that is CHAR 10
unique within the healthcare
facility.
Alpha-numeric. Consistent with Uniquely identifies a patient
CIHI NACRS and DAD definition within an ICP. Necessary to
and format.
determine a case.
If alpha, must be upper case. Foundational to most
measures and indicators.
Clinic Visit
Visit Hospital
Number
MOHLTC Master Number
identifying the hospital site
where this visit occurred.
Same as CIHI’s Institution
Number for NACRS or DAD
submissions, but does not
include CIHI’s provincial
identifier digit.
For current valid MOHLTC
master numbers, see Appendix
A.
Clinic Visit
Submitting
Hospital
Number
MOHLTC facility number of CHAR 4
the hospital organization
Numeric
submitting this visit to CCO.
CCO DataBook 2008-2009
Format
CHAR 4
Numeric
Valid Values
Purpose and Use
Applies to
2008/2009
changes
All
Allows the hospital
All
organization submitting the
data to be distinguished from
the hospital site where the
service was delivered.
Valid MOHLTC facility numbers Uniquely identifies the
All
only. Same 3-digit number thathospital organization to which
is used for MIS submissions.
this visit belongs.
An additional leading zero is
acceptable.
For current valid MOHLTC
facility numbers, see Appendix
A.
17
Clinic Visit
Entity
Data Element
Definition
Format
Valid Values
Purpose and Use
Applies to
2008/2009
changes
Clinic Visit
Visit Date
Date of this visit.
YYYYMMDD
Valid dates only.
Foundational to most
measures and indicators –
ALR, Wait Times, Funding.
Used as a proxy for Consult
date for Wait Times. 1st
Consult date will be used for
Wait Time
All
Revised
Clinic Visit
Visit Time
Time of this activity.
HHMM
0000 (midnight) to 2359, as
per CIHI NACRS format.
Used for NACRS.
OPIS only
Clinic Visit
HCP Number
Healthcare professional
identifier code for the
physician or non-physician
who consulted with the
patient on this visit.
This code is unique to the
submitting ICP.
CHAR 15
Numeric only as per CIHI
NACRS format.
For physicians, this code has
historically been the physician’s
OHIP billing number in OPIS.
Uniquely identifies a health
care professional (physician
or non-physician) so patient
activity can be linked to a
program.
All
Clinic Visit
Visit Program
Code
Program in which case is
registered.
CHAR 3
RAD=Radiation Therapy
SYS = Systemic Therapy
SUR = Surgery
PO = Preventive Oncology
PA = Palliative Care
Used to classify visits by
Program.
All
Clinic Visit
MIS Functional MOHLTC OHRS Functional
Centre
Centre
CHAR 9
Valid MOHLTC Functional Centre To be able to align CCO
Only
activity data to MOHLTC
For current valid MOHLTC
OHRS reporting standards.
Functional centre numbers, see
Appendix 1
All
Clinic Visit
Radiation
Review Flag
CHAR 1
R if this is a rad review, or NULLUsed for ALR.
if not.
All
CCO DataBook 2008-2009
Identifies physician reviews
that occur in the radiation
therapy area during a
patient’s course of
treatment.
18
Clinic Visit
Entity
Data Element
Definition
Clinic Visit
Inpatient Flag
Clinic Visit
Registration
Date
Clinic Visit
Valid Values
Purpose and Use
Applies to
Identifies whether the
CHAR 1
patient is currently
registered as an inpatient at
this ICP.
Date this patient was first
YYYYMMDD
registered at this ICP for this
disease, or the date of the
patient’s first visit at this ICP
for this disease.
Y=Yes for inpatient, N=No.
Used to identify activity
provided to inpatients.
All
Disease
Sequence
Number
Numeric sequence of this
primary cancer for this
patient in this ICP.
Captured in OPIS, but
derived from Disease
Registration Date for nonOPIS ICPs.
1 through 99.
Clinic Visit
Patient Postal
Code
Patient’s postal code of their CHAR 10
home address on the date of
this visit.
Clinic Visit
Patient MOHLTC Patient’s residence code of
Residence Code their home address on the
date of visit.
CCO DataBook 2008-2009
Format
INTEGER
CHAR 4
2008/2009
changes
Valid dates only.
Used as a proxy for Referral All
Date must be equal to or before Date if missing for wait times.
patient’s first visit at this centre Used to derive Disease
Number for non-OPIS ICPs.
for this disease.
When combined with a patientOPIS only
identifier, disease sequence
number uniquely defines a
cancer case.
Used in ALR, Ontario Cancer
Registry, Wait Times,
Planning, and funding.
Canadian postal codes must be Used for generating
in the format ANANAN (no
prevalence rates by region,
space), where A is a letter and and for registry linking.
N is a number. For US zip
Planning, Ontario Cancer
codes, use either NNNNN or
Registry.
NNNNN-NNNN. CIHI’s two-letter
province/ state codes are also
acceptable if full code not
known. See Appendix 9
Revised
All
Numeric only. Must be a valid Used for calculating incidence OPIS only,
MOHLTC residence code. See rates by MOHLTC region.
optional
Appendix B.
Ontario Cancer Registry.
Revised
19
Clinic Visit
Entity
Data Element
Definition
Clinic Visit
Visit Type
OPIS field that distinguishes CHAR 2
telephone visits from faceto-face visits.
CCO DataBook 2008-2009
Format
Valid Values
Purpose and Use
As per OPIS manual. Visit Type Used for NACRS only.
= OM is used to identify
telephone visits.
Applies to
2008/2009
changes
OPIS only,
optional
20
Radiation Planning/ Treatment Activity
ALR > Radiation Planning / Treatment Activity
Entity
Data Element
Definition
Format
Radiation
Planning/
Treatment
Activity
Patient Chart
Number
Patient identifier code that is
unique within the healthcare
facility.
CHAR 10
Consistent with CIHI
Alpha-numeric. NACRS and DAD
definition and format.
Radiation
Planning/
Treatment
Activity
Visit Hospital
Number
MOHLTC Master Number
identifying the hospital site
where this activity occurred.
CHAR 4
Numeric
Radiation
Planning/
Treatment
Activity
Submitting
Hospital
Number
MOHLTC facility number of the CHAR 4
hospital organization
Numeric
submitting this activity to
CCO.
Radiation
Planning/
Treatment
Activity
MIS Functional MOHLTC OHRS Functional
Centre
Centre
CHAR 9
Radiation
Planning/
Treatment
Activity
Radiation
Planning/
Treatment
Activity
Visit Date
Date of this activity.
YYYYMMDD
Visit Time
Time of this activity.
HHMM
CCO DataBook 2008-2009
Valid Values
Purpose and Use
Applies to:
2008/09Changes
Uniquely identifies a patient
All
within an ICP. Necessary to
determine a case.
Foundational to most
measures and indicators.
Allows the hospital
All
organization submitting the
data to be distinguished from
the hospital site where the
service was delivered.
Same as CIHI’s
Institution Number for
NACRS or DAD
submissions, but does
not include CIHI’s
provincial identifier digit.
For current valid MOHLTC
master numbers, see
Appendix A.
Valid MOHLTC facility
Uniquely identifies the hospital All
numbers only. Same 3- organization to which this
digit number that is used activity belongs.
for MIS submissions. An
additional leading zero is
acceptable.
For current valid MOHLTC
facility numbers, see
Appendix A.
Valid MOHLTC Functional To be able to align CCO
All
Centre Only
activity data to MOHLTC OHRS
For current valid MOHLTC reporting standards.
Functional centre
numbers, see Appendix 1
Valid dates only.
Foundational to most
All
measures and indicators. Also
used for funding.
0000 (midnight) to 2359, Used for NACRS.
as per CIHI NACRS
format.
OPIS only
21
Radiation Planning/ Treatment Activity
Entity
Data Element
Definition
Radiation
Planning/
Treatment
Activity
Course of
Radiation
Treatment
Radiation
Planning/
Treatment
Activity
Course
Complete Flag
Radiation
Planning/
Treatment
Activity
NHPIP Code
The course number of the
INTEGER
radiation treatment.
A course is a consecutive
series of radiation treatments
to a specific treatment volume
characterized by a distinct
radiation dose and
fractionation schedule. A
course includes all activities
associated with the planning,
simulation, dosimetry,
treatment, monitoring and
other support activities
associated with the delivery of
care.
Applicable to all NHPIP activity
codes.
Indicates if this treatment
CHAR 1
activity is the last activity in
this course of treatment.
Not applicable for nontreatment NHPIP activity
codes.
National Health Productivity
CHAR 4
Improvement Program activity
code for radiation therapy
workload.
Radiation
Planning/
Treatment
Activity
Body Region
Code
Body region receiving this
activity.
Applies to both planning and
treatment NHPIP activity
codes.
Radiation
Planning/
Treatment
Activity
Dose per
Fraction
Tumour absorbed dose (TAD) REAL
for this fraction in Gray. For
Photodynamic Therapy, the
unit is J/cm2. Only applicable
for treatment NHPIP activity
codes.
CCO DataBook 2008-2009
Format
CHAR 4
Valid Values
Purpose and Use
Applies to:
1 through 99.
Used for funding and activity
measurements.
All
Y=Yes for complete,
N=No.
Used in funding calculations.
All
NHPIP codes define
different radiation tasks.
See NHPIP list and
descriptions in Appendix
E.
See CCO body region
codes in Appendix F.
All
Identifies ALR activity types
and allows calculation of
fractions. May also be used to
calculate course and funding.
For planning activities,
dose should be NULL.
For treatment activities,
dose should be any
positive real number.
2008/09Changes
Identifies body region treated. All
Used for research analysis and
funding by identifying courses.
Concordance with evidencebased practice guidelines,
research analyses, Ontario
Cancer Registry.
All
22
Radiation Planning/ Treatment Activity
Entity
Data Element
Definition
Radiation
Planning/
Treatment
Activity
Intent of
Radiation
Treatment
The intent of radiation
CHAR 1
treatment as determined by
the radiation oncologist at the
time of booking the planning/
treatment visit.
Radiation
Planning/
Treatment
Activity
Radiation
Planning/
Treatment
Activity
Radiation
Planning/
Treatment
Activity
Inpatient Flag
Identifies whether the patient CHAR 1
is currently registered as an
inpatient at this ICP.
Chemo Flag
Identifies whether the patient CHAR 1
received chemo/hormones
outside the ICP prior to
radiation treatment.
Identifies if this course of
CHAR 1
radiation treatment is part of a
clinical trial.
Radiation
Planning/
Treatment
Activity
Registration
Date
Radiation
Planning/
Treatment
Activity
Disease
Sequence
Number
Radiation
Planning/
Treatment
Activity
HCP Number
Clinical Trial
Flag
CCO DataBook 2008-2009
Format
Date this patient was first
YYYYMMDD
registered at this ICP for this
disease, or the date of the
patient’s first visit at this ICP
for this disease.
The numeric sequence of this INTEGER
primary cancer for this patient
in this ICP.
Captured in OPIS, but derived
from Disease Registration Date
for non-OPIS ICPs.
Healthcare professional
CHAR 15
identifier code for the
physician or non-physician
who consulted with the patient
on this visit.
This code is unique to the
submitting ICP.
Valid Values
Purpose and Use
Applies to:
2008/09Changes
C = Curative, P =
Palliative,
A = Adjuvant, or N =
Neoadjuvant.
Enter U for Unknown
See Appendix J for
definitions of each term.
Y=Yes for inpatient,
N=No.
Concordance with evidencebased practice guidelines.
Also used for funding.
All
Revised
Used to identify activity
provided to inpatients.
All
Y = Yes or N = No
Used to exclude cases that
received chemo/hormones
outside the ICPs.
All
Y = Yes or N = No
Allows exclusion of patients on All
clinical trials from analyses of
concordance with evidencebased practice guidelines.
Valid dates only.
Date must be equal to or
before patient’s first visit
at this centre for this
disease.
1 through 99.
Used as a proxy for Referral
All
Date if missing for wait times.
Used to derive Disease
Number for non-OPIS ICPs.
When combined with a patient OPIS only
identifier, disease sequence
number uniquely defines a
cancer case.
Used in ALR, Ontario Cancer
Registry, Wait Times,
Planning, and Funding.
All
Numeric only as per CIHI Uniquely identifies a health
NACRS format.
care professional (physician or
For physicians, this code non-physician) so patient
has historically been the activity can be linked to a
physician’s OHIP billing program.
number in OPIS.
23
Radiation Planning/ Treatment Activity
Entity
Data Element
Radiation
Planning/
Treatment
Activity
Decision to
Treat Date
Radiation
Planning/
Treatment
Activity
Radiation
Planning/
Treatment
Activity
Definition
Format
Date on which sufficient pre- YYYYMMDD
treatment testing is complete,
the physician can reasonably
assume that patient will be
treated, and the patient has
agreed to the treatment.
If the patient is not proceeding
straight to that modality of
treatment but has a planned
delay (other treatment first,
patient choice or physician
choice) then “Ready to Treat”
date needs to be specified.
Otherwise, the DTT date is the
same as the RTT date.
For radiation, the decision-totreat date is when the patient
is ready to proceed to
planning.
Ready to Treat Date on which all preYYYYMMDD
Date
treatment testing is complete
or when any planned delay is
over, and the patient is ready
to begin treatment from both
a social/personal and medical
perspective.
Urgency
A triage categorization for wait CHAR 1
Category
times reporting. See Appendix
W for detailed definitions.
CCO DataBook 2008-2009
Valid Values
Purpose and Use
Applies to:
Valid dates only.
Used in wait times reports.
Must be equal to or later
than the first consult
date. Must be equal to
or earlier than the first
treatment date.
All
Valid dates only.
Used in wait times reports.
Must be equal to or later
than the first consult
date. Must be equal to
or earlier than the first
treatment date.
All
See Appendix W for
category definitions.
All
Used in wait times reports.
2008/09Changes
24
Radiation Planning/ Treatment Activity
Entity
Data Element
Definition
Format
Valid Values
Radiation
Planning/
Treatment
Activity
Patient Postal
Code
Patient’s postal code of their
home address on the date of
this activity.
CHAR 10
Radiation
Planning/
Treatment
Activity
Patient MOHLTC Patient’s residence code of
Residence Code their home address on the
date of activity.
Canadian postal codes
Used for generating
All
must be in the format
prevalence rates by region,
and for registry linking.
ANANAN (no space),
where A is a letter and N Planning, Ontario Cancer
is a number. For US zip Registry.
codes, use either NNNNN
or NNNNN-NNNN. CIHI’s
two-letter province/state
codes are also acceptable
if full code not known or
for non-Canadian
residence. See Appendix
9.
Numeric only. Must be a Used for calculating incidence OPIS only,
valid MOHLTC residence rates by MOHLTC region.
optional
code. See Appendix B. Ontario Cancer Registry.
CCO DataBook 2008-2009
CHAR 4
Purpose and Use
Applies to:
2008/09Changes
Revised
Revised
25
Systemic Drug Delivery Event
ALR > Systemic Drug Delivery Event
Entity
Definition
Format
Systemic Drug Patient Chart
Delivery Event Number
Data Element
Patient identifier code that is
unique within the healthcare
facility.
CHAR 10
Consistent with CIHI
Alpha-numeric. NACRS definition and
format.
Systemic Drug Visit Hospital
Delivery Event Number
MOHLTC Master Number
identifying the hospital site
where this activity occurred.
CHAR 4
Numeric
Systemic Drug Submitting
Delivery Event Hospital
Number
MOHLTC facility number of the CHAR 4
hospital organization
Numeric
submitting this event to CCO.
Systemic Drug MIS Functional MOHLTC OHRS Functional
Centre
Delivery Event Centre
CHAR 9
Systemic Drug Visit Date
Delivery Event
YYYYMMDD
CCO DataBook 2008-2009
Date of this drug delivery
event.
Valid Values
Purpose and Use
Applies to:
2008/09Changes
Uniquely identifies a patient
All
within an ICP. Necessary to
determine a case.
Foundational to most
measures and indicators.
Allows the hospital
All
organization submitting the
data to be distinguished from
the hospital site where the
service was delivered.
Same as CIHI’s
Institution Number for
NACRS or DAD
submissions, but does
not include CIHI’s
provincial identifier digit.
For current valid MOHLTC
master numbers, see
Appendix A.
Valid MOHLTC facility
Uniquely identifies the hospital All
numbers only. Same 3- organization to which this
digit number that is used event belongs.
for MIS submissions. An
additional leading zero is
acceptable.
For current valid MOHLTC
facility numbers, see
Appendix A.
Valid MOHLTC Functional To be able to align CCO
All
Centre Only
activity data to MOHLTC OHRS
For current valid MOHLTC reporting standards.
Functional centre
numbers, see Appendix 1
Valid dates only.
Foundational to most
All
measures and indicators –
ALR, Wait Times, and funding.
26
Systemic Drug Delivery Event
Entity
Data Element
Systemic Drug Visit Time
Delivery Event
Definition
Format
Valid Values
Time of this activity.
HHMM
0000 (midnight) to 2359, Used for NACRS and ALR to
as per CIHI NACRS
identify multiple visits in the
format.
same day.
See Appendix LL for a list Concordance with evidenceof CCO regimen names. based practice guidelines,
In cases where the
funding.
Regimen is not in the
CCO regimen list, an ICP
regimen name is
acceptable.
As per OPIS 2000 or
Uniquely identifies a generic
OPIS 2005 drug tables. drug.
Concordance with evidencebased practice guidelines,
funding.
Systemic Drug CCO Regimen
Delivery Event
A set of anti-cancer and
CHAR 22
supportive medications given
during an active course of
systemic chemotherapy that is
named and defined in CCO’s
Provincial Formulary Regimen
List.
Systemic Drug CCO Drug Code CCO hybrid of the First Data CHAR 10
Bank (FDB) drug number as it
Delivery Event
appears in OPIS 2000 or
OPIS 2005.
Mandatory for OPIS ICPs only.
Non-OPIS ICPs use the DIN
instead.
Systemic Drug DIN
Health Canada Drug
CHAR 8
Identification Number.
Delivery Event
Systemic Drug Drug Origin Flag Flag generated automatically CHAR 1
by OPIS to indicate the origin
Delivery Event
of the drug.
Systemic Drug Body Surface
Delivery Event Area
CCO DataBook 2008-2009
Body surface area of the
REAL
patient, calculated based on
their height and weight using
the MEDLOG formula.
Purpose and Use
Applies to:
2008/09Changes
OPIS only
All
OPIS only
Valid Health Canada
Uniquely identifies the drug
Non-OPIS only
DINs.
product, as to its
For clinical trial drugs not manufacturer, name and
yet approved by Health strength of active ingredients,
route of administration and
Canada, use the value
9999999A for
pharmaceutical dosage form.
antineoplastic trial drugs Used to identify drugs and to
or 9999999S for
link to CCO drug codes for
supportive trial drugs.
non-OPIS ICPs.
Y=Yes if FDB
Identifies if the drug is
OPIS only
N= No if not
supplied by FDB or created as
FDB/investigational
an investigational drug.
created by OPIS
Used to uniquely identify the
drug given.
Any positive real
Concordance with evidenceAll
number.
based practice guidelines.
27
Systemic Drug Delivery Event
Entity
Data Element
Systemic Drug Dose
Delivery Event Administered
Systemic Drug Measurement
Delivery Event Unit
Systemic Drug Route
Delivery Event
Systemic Drug Intent of
Delivery Event Systemic
Treatment
Definition
Format
Actual dose administered
REAL
during this visit (total amount
as opposed to metres
squared).
If the prescribed dose is the
only dose available for some
non-OPIS ICPs, this is
acceptable. However, dose
administered is preferred.
Unit of measurement
CHAR 3
pertaining to the dose of this
drug.
Route used to administer this CHAR 3
drug (e.g. intravenous).
Intent of systemic treatment
as determined by the
oncologist at the time of
booking the treatment visit.
CHAR 1
Systemic Drug Line of Therapy Each line of therapy given to a Integer
Delivery Event
patient for incurable disease
(palliative intent) refers to a
regimen given to control
disease. One regimen is
changed to another (one more
line of therapy) once disease
progresses in spite of
treatment or there is
intolerable toxicity. Changing
therapy implies that the
disease is more advanced and
more complicated, or toxicity
is complicating treatment.
Systemic Drug Inpatient Flag Identifies whether the patient CHAR 1
is currently registered as an
Delivery Event
inpatient at this ICP.
CCO DataBook 2008-2009
Valid Values
Purpose and Use
Any non-negative real
number.
If the dose is zero, CCO
assumes the patient
arrived at the clinic but
was not treated with this
drug as planned.
Used to support cancer system All
planning and funding.
Concordance with evidencebased guidelines and funding.
Applies to:
2008/09Changes
See Appendix K for CCO Concordance with evidenceAll
measurement unit codes. based guidelines and funding.
For current valid OPIS
Used to categorize drugs for All
route codes and
analysis purposes.
description, see Appendix
L.
C = Curative, P =
Concordance with evidenceAll
Palliative,
based guidelines and funding.
A = Adjuvant, or N =
Neoadjuvant
Enter U for Unknown
See Appendix J for
definitions of each term.
1 through 99
To identify line of therapy in
All
treating disease
Y=Yes for inpatient,
N=No
Used to identify activity
provided to inpatients.
Revised
New
All
28
Systemic Drug Delivery Event
Entity
Data Element
Systemic Drug Clinical Trial
Delivery Event Flag
Definition
Format
Valid Values
Identifies if this systemic
treatment event is part of a
clinical trial.
CHAR 1
Y = Yes or N = No
Systemic Drug Arrived But Not A flag identifying if the patient CHAR 1
arrived for treatment but did
Delivery Event Treated
not receive it.
Systemic Drug Registration
Delivery Event Date
Systemic Drug Disease
Delivery Event Sequence
Number
Systemic Drug HCP Number
Delivery Event
CCO DataBook 2008-2009
Date this patient was first
YYYYMMDD
registered at this ICP for this
disease, or the date of the
patient’s first visit at this ICP
for this disease.
Numeric sequence of this
INTEGER
primary cancer for this patient
in this ICP.
Captured in OPIS, but derived
from Disease Registration Date
for non-OPIS ICPs.
Healthcare professional
CHAR 15
identifier code for the
physician or non-physician
who consulted with the patient
on this visit.
This code is unique to the
submitting ICP.
Purpose and Use
Applies to:
2008/09Changes
Allows exclusion of patients on All
clinical trials from analyses of
concordance with evidencebased practice guidelines.
Y = Yes or N = No
Identifies those patients who All
arrive in a suite but are
medically unable or unwilling
to receive treatment.
Used for ALR, NACRS, MIS,
and funding.
All
Valid dates only.
Used as a proxy for Referral
Date must be equal to or Date if missing for wait times.
before patient’s first visit Used to derive Disease
Number for non-OPIS ICPs.
at this centre for this
disease.
1 through 99.
When combined with a patient OPIS only
identifier, disease sequence
number uniquely defines a
cancer case.
Used in ALR, Ontario Cancer
Registry, Wait Times,
Planning, and funding.
All
Numeric only as per CIHI Uniquely identifies a health
NACRS format.
care professional (physician or
For physicians, this code non-physician) so patient
has historically been the activity can be linked to a
physician’s OHIP billing program.
number in OPIS.
29
Systemic Drug Delivery Event
Entity
Data Element
Definition
Format
Systemic Drug Decision to
Delivery Event Treat Date
Date on which sufficient pre- YYYYMMDD
treatment testing is complete,
the physician can reasonably
assume that patient will be
treated, and the patient has
agreed to the treatment.
If the patient is not proceeding
straight to that modality of
treatment but has a planned
delay (other treatment first,
patient choice or physician
choice) then “Ready to Treat”
date needs to be specified.
Otherwise, the DTT date is the
same as the RTT date.
Systemic Drug Ready to Treat Date on which all preYYYYMMDD
treatment testing is complete
Delivery Event Date
and when any planned delay is
over, and the patient is ready
to begin treatment from both
a social/personal and medical
perspective.
Systemic Drug Urgency
A triage categorization for wait CHAR 1
Delivery Event Category
times reporting.
Systemic Drug Patient Postal Patient’s postal code of their CHAR 10
home address on the date of
Delivery Event Code
this event.
Systemic Drug Patient MOHLTC Patient’s residence code of
Delivery Event Residence Code their home address on the
date of event.
CCO DataBook 2008-2009
CHAR 4
Valid Values
Purpose and Use
Applies to:
Valid dates only.
Used in wait times reports.
Must be equal to or later
than the first consult
date. Must be equal to
or earlier than the first
treatment date.
All
Valid dates only.
Used in wait times reports.
Must be equal to or later
than the first consult
date. Must be equal to
or earlier than the first
treatment date.
All
See Appendix W for
Used in wait times reports.
category definitions.
Used for generating
Canadian postal codes
prevalence rates by region,
must be in the format
and for registry linking.
ANANAN (no space),
where A is a letter and N Planning, Ontario Cancer
is a number. For US zip Registry.
codes, use either NNNNN
or NNNNN-NNNN. CIHI’s
two-letter province/state
codes are also acceptable
if full code not known or
for non-Canadian
residence. See Appendix
9.
Numeric only. Must be a Used for calculating incidence
valid MOHLTC residence rates by MOHLTC region.
code. See Appendix B. Ontario Cancer Registry.
All
2008/09Changes
All
Revised
OPIS only,
optional
Revised
30
Systemic Drug Delivery Event
CCO DataBook 2008-2009
31
procedure
ALR > Procedure
Entity
Data Element
Definition
Procedure
Patient Chart
Number
Patient identifier code that is
unique within the healthcare
facility.
Procedure
Procedure
Procedure
Procedure
Procedure
Format
Valid Values
Purpose and Use
Applies To:
2008/09 Changes
CHAR 10
Consistent with CIHI
Uniquely identifies a patient
All
Alpha-numeric. NACRS and DAD
within an ICP. Necessary to
definition and format.
determine a case.
If alpha, then must be
Foundational to most
upper case.
measures and indicators.
Visit Hospital
MOHLTC Master Number
CHAR 4
Same as CIHI’s
Allows the hospital
All
Number
identifying the hospital site
Numeric
Institution Number for
organization submitting the
where this procedure
NACRS or DAD
data to be distinguished from
occurred.
submissions, but does
the hospital site where the
not include CIHI’s
service was delivered.
provincial identifier digit.
For current valid MOHLTC
master numbers, see
Appendix A.
Submitting
MOHLTC facility number of the CHAR 4
Valid MOHLTC facility
Uniquely identifies the hospital All
Hospital Number hospital organization
Numeric
numbers only. Same 3- organization to which this
submitting this event to CCO.
digit number that is used event belongs.
for MIS submissions. An
additional leading zero is
acceptable.
For current valid MOHLTC
facility numbers, see
Appendix A.
MIS Functional MOHLTC OHRS Functional
CHAR 9
Valid MOHLTC Functional To be able to align CCO
All
Centre
Centre
Centre Only
activity data to MOHLTC OHRS
For current valid MOHLTC reporting standards.
Functional centre
numbers, see Appendix 1
Visit Date
Date of this procedure.
YYYYMMDD
Valid dates only.
Foundational to most
All
measures and indicators –
ALR, Wait Times and Funding.
Visit Time
Time of this procedure.
HHMM
0000 (midnight) to 2359, Used for NACRS and ALR to
OPIS only
as per CIHI NACRS
identify multiple visits in the
format.
same day.
CCO DataBook 2008-2009
32
procedure
Entity
Data Element
Procedure
CHAR 10
Procedure Code The CIHI CCI or CCP
procedure code describing the
procedure administered to the
patient, usually in the
systemic treatment area.
This is NOT for surgical
procedures, which are
reported through the DAD and
NACRS data submissions to
CIHI.
Inpatient Flag
Identifies whether the patient CHAR 1
is currently registered as an
inpatient at this ICP.
Procedure
Procedure
HCP Number
Procedure
Visit Program
Code
Procedure
Patient Postal
Code
CCO DataBook 2008-2009
Definition
Format
Healthcare professional
CHAR 15
identifier code for the
physician or non-physician
who consulted with the patient
on this visit.
This code is unique to the
submitting ICP.
Program in which case is
CHAR 3
registered.
Patient’s postal code of their
home address on the date of
this procedure.
CHAR 10
Valid Values
Purpose and Use
Applies To:
OPIS ICPs: CCP
Used to track minor
procedure codes as they procedures that occur in the
exist in OPIS.
systemic treatment areas.
Non-OPIS ICPs: CCI
intervention codes as per
ICD-10-CA.
All
Y=Yes for inpatient,
N=No
Used to identify activity
provided to inpatients.
All
Numeric only as per CIHI
NACRS format.
For physicians, this code
has historically been the
physician’s OHIP billing
number in OPIS.
Uniquely identifies a health
All
care professional (physician or
non-physician) so patient
activity can be linked to a
program.
RAD=Radiation Therapy Used to classify visits by
SYS = Systemic Therapy Program.
SUR = Surgery
PO = Preventive
Oncology
PA = Palliative Care
For generating prevalence
Canadian postal codes
rates by region, and for
must be in the format
registry linking.
ANANAN (no space),
where A is a letter and N Planning, Ontario Cancer
is a number. For US zip Registry.
codes, use either NNNNN
or NNNNN-NNNN. CIHI’s
two-letter province/state
codes are also acceptable
if full code not known or
for non-Canadian
residence. See Appendix
9.
2008/09 Changes
All
All
Revised
33
procedure
Entity
Data Element
Procedure
Patient MOHLTC The patient’s residence code of CHAR 4
Residence Code their home address on the
date of procedure.
Registration
Date this patient was first
YYYYMMDD
Date
registered at this ICP for this
disease, or the date of the
patient’s first visit at this ICP
for this disease.
Disease means a primary
cancer.
Disease
Numeric sequence of this
INTEGER
Sequence
primary cancer for this patient
Number
in this ICP.
Captured in OPIS, but derived
from Disease Registration Date
for non-OPIS ICPs.
Procedure
Procedure
CCO DataBook 2008-2009
Definition
Format
Valid Values
Purpose and Use
Numeric only. Must be a
valid MOHLTC residence
code. See Appendix B.
Valid dates only.
Date must be equal to or
before patient’s first visit
at this centre for this
disease.
For calculating incidence rates OPIS only,
by MOHLTC region.
optional
Ontario Cancer Registry.
Used as a proxy for Referral
All
Date if missing for wait times.
Used to derive Disease
Sequence Number for nonOPIS ICPs.
Applies To:
1 through 99.
When combined with a patient OPIS only
identifier, disease sequence
number uniquely defines a
cancer case.
Used in ALR, Ontario Cancer
Registry, Wait Times,
Planning, and funding.
2008/09 Changes
Revised
34
NDFP Enrollment
ALR > NDFP Enrollment
Entity
Data Element Definition
Format
Valid Values
Purpose and Use
Applies To:
for
NDFP
Visit Hospital MOHLTC Master
CHAR 4
Enrollment Number
Number identifying Numeric
the hospital site
where this activity
occurred.
for
NDFP
Submitting
Enrollment Hospital
Number
NDFP
NDFP Form
Enrollment Number
NDFP
NDFP Form
Enrollment Version
Number
MOHLTC facility
CHAR 4
number of the
Numeric
hospital
organization
submitting this
enrollment to CCO.
Identifying number CHAR 3
of the NDFP
Numeric
eligibility form.
Version number of CHAR 3
the NDFP eligibility Numeric
form.
CHAR 15
NDFP
HCP Number Healthcare
Enrollment
professional
identifier code for
the physician who
is managing this
systemic
treatment.
This code is unique
to the submitting
ICP.
CCO DataBook 2008-2009
Uniquely identifies a
OPIS, optional
patient within an ICP.
non-OPIS
Necessary to determine a
case. Foundational to
most measures and
indicators.
Same as CIHI’s Institution Number for
Allows the hospital
OPIS, optional
NACRS or DAD submissions, but does not organization submitting non-OPIS
include CIHI’s provincial identifier digit. the data to be
For current valid MOHLTC master
distinguished from the
numbers, see Appendix A.
hospital site where the
service was delivered.
Valid MOHLTC facility numbers only.
Uniquely identifies the
OPIS, optional
Same 3-digit number that is used for MIS hospital organization to non-OPIS
submissions. An additional leading zero which this enrollment
is acceptable.
belongs.
For current valid MOHLTC facility
numbers, see Appendix A.
OPIS, optional
As per revised NDFP forms which will be Identifies the drug,
disease, and defines the non-OPIS
available early in 2006. See
http://www.cancercare.on.ca/index_canc relevant answer fields
required.
erDrugs.htm
As per revised NDFP forms which will be Identifies the drug,
OPIS, optional
available in early 2006.
disease, and defines the non-OPIS
relevant answer fields
required.
Numeric only as per CIHI NACRS format. Uniquely identifies a
OPIS, optional
This code has historically been the
physician so patient
non-OPIS
physician’s OHIP billing number in OPIS. activity can be linked to
a program.
2008/09 Changes
NDFP
Patient Chart Patient identifier
CHAR 10
Consistent with CIHI NACRS and DAD
Enrollment Number
code that is unique Alpha-numeric definition and format.
If alpha, then must be upper case.
within the
healthcare facility.
for
for
for
for
35
NDFP Enrollment
Entity
Data Element Definition
NDFP
Date of First
Enrollment Treatment
Format
NDFP
Height
Enrollment
Date of the this
YYYYMMDD
patient’s first drug
administration for
this regimen.
Patient height in
REAL
cm.
NDFP
Weight
Enrollment
Patient weight in
kg.
Valid Values
Purpose and Use
Applies To:
Valid dates only.
Allows enrollment to be
linked to the systemic
treatment event.
OPIS, optional for
non-OPIS
2008/09 Changes
Any positive real number.
Used to confirm patient OPIS, optional
eligibility for this drug.
non-OPIS
Used for system planning
and budgeting.
Used to confirm patient OPIS, optional
eligibility for this drug.
non-OPIS
Used for system planning
and budgeting.
Used to confirm patient OPIS, optional
eligibility for this drug.
non-OPIS
Used for system planning
and budgeting.
Used to confirm patient OPIS, optional
eligibility for this drug.
non-OPIS
for
REAL
Any positive real number.
NDFP
Body Surface Patient body
REAL
Enrollment Area
surface area in m2.
Any positive real number.
NDFP
Eligibility
Enrollment Answer 1
CHAR 1
Determined by the enrollment form.
CHAR 1
Determined by the enrollment form.
Used to confirm patient
eligibility for this drug.
OPIS, optional for
non-OPIS
CHAR 1
Determined by the enrollment form.
Used to confirm patient
eligibility for this drug.
OPIS, optional for
non-OPIS
CHAR 1
Determined by the enrollment form.
Used to confirm patient
eligibility for this drug.
OPIS, optional for
non-OPIS
CHAR 1
Determined by the enrollment form.
Used to confirm patient
eligibility for this drug.
OPIS, optional for
non-OPIS
CHAR 1
Determined by the enrollment form.
Used to confirm patient
eligibility for this drug.
OPIS, optional for
non-OPIS
NDFP
Eligibility
Enrollment Answer 2
NDFP
Eligibility
Enrollment Answer 3
NDFP
Eligibility
Enrollment Answer 4
NDFP
Eligibility
Enrollment Answer 5
NDFP
Eligibility
Enrollment Answer 6
CCO DataBook 2008-2009
Answer to an
eligibility question
on an enrollment
form.
Answer to an
eligibility question
on an enrollment
form.
Answer to an
eligibility question
on an enrollment
form.
Answer to an
eligibility question
on an enrollment
form.
Answer to an
eligibility question
on an enrollment
form.
Answer to an
eligibility question
on an enrollment
form.
for
for
for
36
NDFP Enrollment
Entity
Data Element Definition
NDFP
Eligibility
Enrollment Answer 7
NDFP
Eligibility
Enrollment Answer 8
NDFP
Eligibility
Enrollment Answer 9
NDFP
Eligibility
Enrollment Answer 10
NDFP
Eligibility
Enrollment Answer 11
NDFP
Eligibility
Enrollment Answer 12
NDFP
Eligibility
Enrollment Answer 13
NDFP
Eligibility
Enrollment Answer 14
NDFP
Eligibility
Enrollment Answer 15
NDFP
Eligibility
Enrollment Answer 16
CCO DataBook 2008-2009
Answer to an
eligibility question
on an enrollment
form.
Answer to an
eligibility question
on an enrollment
form.
Answer to an
eligibility question
on an enrollment
form.
Answer to an
eligibility question
on an enrollment
form.
Answer to an
eligibility question
on an enrollment
form.
Answer to an
eligibility question
on an enrollment
form.
Answer to an
eligibility question
on an enrollment
form.
Answer to an
eligibility question
on an enrollment
form.
Answer to an
eligibility question
on an enrollment
form.
Answer to an
eligibility question
on an enrollment
form.
Format
Valid Values
Purpose and Use
Applies To:
CHAR 1
Determined by the enrollment form.
Used to confirm patient
eligibility for this drug.
OPIS, optional for
non-OPIS
CHAR 1
Determined by the enrollment form.
Used to confirm patient
eligibility for this drug.
OPIS, optional for
non-OPIS
CHAR 1
Determined by the enrollment form.
Used to confirm patient
eligibility for this drug.
OPIS, optional for
non-OPIS
CHAR 1
Determined by the enrollment form.
Used to confirm patient
eligibility for this drug.
OPIS, optional for
non-OPIS
CHAR 1
Determined by the enrollment form.
Used to confirm patient
eligibility for this drug.
OPIS, optional for
non-OPIS
CHAR 1
Determined by the enrollment form.
Used to confirm patient
eligibility for this drug.
OPIS, optional for
non-OPIS
CHAR 1
Determined by the enrollment form.
Used to confirm patient
eligibility for this drug.
OPIS, optional for
non-OPIS
CHAR 1
Determined by the enrollment form.
Used to confirm patient
eligibility for this drug.
OPIS, optional for
non-OPIS
CHAR 1
Determined by the enrollment form.
Used to confirm patient
eligibility for this drug.
OPIS, optional for
non-OPIS
CHAR 1
Determined by the enrollment form.
Used to confirm patient
eligibility for this drug.
OPIS, optional for
non-OPIS
2008/09 Changes
37
NDFP Enrollment
Entity
Data Element Definition
NDFP
Eligibility
Enrollment Answer 17
NDFP
Eligibility
Enrollment Answer 18
NDFP
Eligibility
Enrollment Answer 19
NDFP
Eligibility
Enrollment Answer 20
NDFP
Eligibility
Enrollment Answer 21
NDFP
Eligibility
Enrollment Answer 22
NDFP
Eligibility
Enrollment Answer 23
NDFP
Eligibility
Enrollment Answer 24
NDFP
Eligibility
Enrollment Answer 25
NDFP
Eligibility
Enrollment Answer 26
CCO DataBook 2008-2009
Answer to an
eligibility question
on an enrollment
form.
Answer to an
eligibility question
on an enrollment
form.
Answer to an
eligibility question
on an enrollment
form.
Answer to an
eligibility question
on an enrollment
form.
Answer to an
eligibility question
on an enrollment
form.
Answer to an
eligibility question
on an enrollment
form.
Answer to an
eligibility question
on an enrollment
form.
Answer to an
eligibility question
on an enrollment
form.
Answer to an
eligibility question
on an enrollment
form.
Answer to an
eligibility question
on an enrollment
form.
Format
Valid Values
Purpose and Use
Applies To:
CHAR 1
Determined by the enrollment form.
Used to confirm patient
eligibility for this drug.
OPIS, optional for
non-OPIS
CHAR 1
Determined by the enrollment form.
Used to confirm patient
eligibility for this drug.
OPIS, optional for
non-OPIS
CHAR 1
Determined by the enrollment form.
Used to confirm patient
eligibility for this drug.
OPIS, optional for
non-OPIS
CHAR 1
Determined by the enrollment form.
Used to confirm patient
eligibility for this drug.
OPIS, optional for
non-OPIS
CHAR 40
Determined by the enrollment form.
Used to confirm patient
eligibility for this drug.
OPIS, optional for
non-OPIS
CHAR 40
Determined by the enrollment form.
Used to confirm patient
eligibility for this drug.
OPIS, optional for
non-OPIS
CHAR 40
Determined by the enrollment form.
Used to confirm patient
eligibility for this drug.
OPIS, optional for
non-OPIS
CHAR 40
Determined by the enrollment form.
Used to confirm patient
eligibility for this drug.
OPIS, optional for
non-OPIS
CHAR 40
Determined by the enrollment form.
Used to confirm patient
eligibility for this drug.
OPIS, optional for
non-OPIS
CHAR 40
Determined by the enrollment form.
Used to confirm patient
eligibility for this drug.
OPIS, optional for
non-OPIS
2008/09 Changes
38
NDFP Enrollment
Entity
Data Element Definition
NDFP
Eligibility
Enrollment Answer 27
NDFP
Eligibility
Enrollment Answer 28
NDFP
Eligibility
Enrollment Answer 29
NDFP
Eligibility
Enrollment Answer 30
CCO DataBook 2008-2009
Answer to an
eligibility question
on an enrollment
form.
Answer to an
eligibility question
on an enrollment
form.
Answer to an
eligibility question
on an enrollment
form.
Answer to an
eligibility question
on an enrollment
form.
Format
Valid Values
Purpose and Use
Applies To:
CHAR 40
Determined by the enrollment form.
Used to confirm patient
eligibility for this drug.
OPIS, optional for
non-OPIS
CHAR 40
Determined by the enrollment form.
Used to confirm patient
eligibility for this drug.
OPIS, optional for
non-OPIS
CHAR 40
Determined by the enrollment form.
Used to confirm patient
eligibility for this drug.
OPIS, optional for
non-OPIS
CHAR 40
Determined by the enrollment form.
Used to confirm patient
eligibility for this drug.
OPIS, optional for
non-OPIS
2008/09 Changes
39